The global Allergic Asthma Therapeutics Market is estimated to be valued at US$ 7.26 Bn or Billion in 2023 and is expected to exhibit a CAGR of 3.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Allergic asthma therapeutics are drugs used to treat patients suffering from allergic asthma. Asthma is caused by inflammation and ... Read more

Allergic asthma therapeutics include drugs that provide relief from asthma symptoms and prevent asthma attacks. There are different types of drugs used in asthma treatment such as short-acting beta2-agonists (SABAs), long-acting beta2-agonists (LABAs), leukotriene modifiers, mast cell stabilizers, monoclonal antibody, and inhaled corticosteroids. These drugs are effective in controlling and managing asthma symptoms and reducing the risk of asthma exacerbations and attacks. The global ... Read more

 Allergic asthma therapeutics aims to treat patients suffering from allergic asthma disorders through anti-inflammatory and bronchodilator drugs. Allergic asthma refers to a type of asthma caused by an allergic reaction to inhaled allergens such as dust mites, pollen, pet dander, or mold. The common symptoms include chest tightness, wheezing, cough and shortness of breath. The global demand for these therapeutics has been rising with increasing cases of allergic asthma worldwide due to ... Read more